Iron overload in patients undergoing hematopoietic stem cell transplantation

Advances in Hematology

Volumn 2010, Issue , 2010, Pages

  Pullarkat, Vinod ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; ERYTHROCYTE TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IRON CHELATION; IRON OVERLOAD; MYCOSIS; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PATIENT CARE; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW; THALASSEMIA;

EID: 77957867132     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2010/345756     Document Type: Review

References (93)

1. Appelbaum F. R., The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer Ca: A Cancer Journal for Clinicians 1996 46 3 142 164
2. Lucarelli G., Gaziev J., Advances in the allogeneic transplantation for thalassemia Blood Reviews 2008 22 2 53 63
3. Andrews N. C., Disorders of iron metabolism The New England Journal of Medicine 1999 341 26 1986 1995
4. Porter J. B., Practical management of iron overload British Journal of Haematology 2001 115 2 239 252
5. Britton R. S., Leicester K. L., Bacon B. R., Iron toxicity and chelation therapy International Journal of Hematology 2002 76 3 219 228
6. Cabantchik Z. I., Breuer W., Zanninelli G., Cianciulli P., LPI-labile plasma iron in iron overload Best Practice and Research: Clinical Haematology 2005 18 2 277 287
7. Hershko C., Link G., Cabantchik I., Pathophysiology of iron overload Annals of the New York Academy of Sciences 1998 850 191 201
8. Pullarkat V., Blanchard S., Tegtmeier B., Dagis A., Patane K., Ito J., Forman S. J., Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation Bone Marrow Transplantation 2008 42 12 799 805
9. Ganz T., Nemeth E., Regulation of iron acquisition and iron distribution in mammals Biochimica et Biophysica Acta 2006 1763 7 690 699
10. Nemeth E., Tuttle M. S., Powelson J., Vaughn M. D., Donovan A., Ward D. M., Ganz T., Kaplan J., Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 2004 306 5704 2090 2093
11. Kanda J., Mizumoto C., Kawabata H., Tsuchida H., Tomosugi N., Matsuo K., Uchiyama T., Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation Haematologica 2008 93 10 1550 1554
12. Sahlstedt L., Ebeling F., von Bonsdorff L., Parkkinen J., Ruutu T., Non-transferrin-bound iron during allogeneic stem cell transplantation British Journal of Haematology 2001 113 3 836 838
13. Durken M., Nielsen P., Knobel S., Finckh B., Herrnring C., Dresow B., Kohlschtter B., Stockschlder M., Kruger W. H., Kohlschtter A., Zander A. R., Nontransferrin-bound iron in serum of patients receiving bone marrow transplants Free Radical Biology and Medicine 1997 22 7 1159 1163
14. Drren M., Herrnring C., Finckh B., Nagel S., Nielsen P., Fischer R., Berger H. M., Moison R. M. W., Pichlmeier U., Kohlschtter B., Zander A. R., Kohlschtter A., Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation Free Radical Biology and Medicine 2000 28 6 887 894
15. McDonald G. B., Shulman H. M., Sullivan K. M., Spencer G. D., Intestinal and hepatic complications of human bone marrow transplantation. Part I Gastroenterology 1986 90 2 460 477
16. Bradley S. J., Gosriwitana I., Srichairatanakool S., Hider R. C., Porter J. B., Non-transferrin-bound iron induced by myeloablative chemotherapy British Journal of Haematology 1997 99 2 337 343
17. Evens A. M., Mehta J., Gordon L. I., Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress Bone Marrow Transplantation 2004 34 7 561 571
18. Durken M., Agbenu J., Finckh B., Hubner C., Pichlmeier U., Zeller W., Winkler K., Zander A., Kohlschutter A., Deteriorating free radical-trapping capacity and antioxidant status in plasma during bone marrow transplantation Bone Marrow Transplantation 1995 15 5 757 762
19. Sari I., Cetin A., Kaynar L., Saraymen R., Hacioglu S. K., Ozturk A., Kocyigit I., Altuntas F., Eser B., Disturbance of pro-oxidative/antioxidative balance in allogeneic peripheral blood stem cell transplantation Annals of Clinical and Laboratory Science 2008 38 2 120 125
20. Clemens M. R., Ladner C., Schmidt H., Ehninger G., Einsele H., Buhler E., Waller H. D., Gey K. F., Decreased essential antioxidants and increased lipid hydroperoxides following high-dose radiochemotherapy Free Radical Research Communications 1989 7 36 227 232
21. Schaible U. E., Kaufmann S. H. E., Iron and microbial infection Nature Reviews Microbiology 2004 2 12 946 953
22. Bullen J. J., Rogers H. J., Spalding P. B., Ward C. G., Natural resistance, iron and infection: a challenge for clinical medicine Journal of Medical Microbiology 2006 55 3 251 258
23. Lucarelli G., Galimberti M., Polchi P., Angelucci E., Baronciani D., Giardini C., Politi P., Durazzi S. M. T., Muretto P., Albertini F., Bone marrow transplantation in patients with thalassemia The New England Journal of Medicine 1990 322 7 417 421
24. Armand P., Kim H. T., Cutler C. S., Ho V. T., Koreth J., Alyea E. P., Soiffer R. J., Antin J. H., Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation Blood 2007 109 10 4586 4588
25. Mahindra A., Bolwell B., Sobecks R., Rybicki L., Pohlman B., Dean R., Andresen S., Sweetenham J., Kalaycio M., Copelan E., Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma Biology of Blood and Marrow Transplantation 2008 14 11 1239 1244
26. Platzbecker U., Bornhuser M., Germing U., Stumpf J., Scott B. L., Krger N., Schwerdtfeger R., Bhm A., Kobbe G., Theuser C., Rabitsch W., Valent P., Sorror M. L., Ehninger G., Deeg H. J., Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS) Biology of Blood and Marrow Transplantation 2008 14 11 1217 1225
27. Kim Y. R., Kim J. S., Cheong J.-W., Song J. W., Min Y. H., Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies Acta Haematologica 2009 120 3 182 189
28. Kataoka K., Nannya Y., Hangaishi A., Imai Y., Chiba S., Takahashi T., Kurokawa M., Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation 2009 15 2 195 204
29. Mahindra A., Sobecks R., Rybicki L., Pohlman B., Dean R., Andresen S., Kalaycio M., Sweetenham J., Bolwell B., Copelan E., Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation Bone Marrow Transplantation 2009 44 11 767 768
30. Lee J. W., Kang H. J., Kim E. K., Kim H., Shin H. Y., Ahn H. S., Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children Bone Marrow Transplantation 2009 44 12 793 797
31. Mahindra A., Bolwell B., Sobecks R., Rybicki L., Pohlman B., Dean R., Andresen S., Sweetenham J., Kalaycio M., Copelan E., Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation British Journal of Haematology 2009 146 3 310 316
32. Iglesias-Osma C., Gonzalez-Villaron L., San Miguel J. F., Caballero M. D., Vazquez L., de Castro S., Iron metabolism and fungal infections in patients with haematological malignancies Journal of Clinical Pathology 1995 48 3 223 225
33. Karp J. E., Merz W. G., Association of reduced total iron binding capacity and fungal infections in leukemic granulocytopenic patients Journal of Clinical Oncology 1986 4 2 216 220
34. Caroline L., Rosner F., Kozinn P. J., Elevated serum iron, low unbound transferrin and candidiasis in acute leukemia Blood 1969 34 4 441 451
35. Von Bonsdorff L., Sahlstedt L., Ebeling F., Ruutu T., Parkkinen J., Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron FEMS Immunology and Medical Microbiology 2003 37 1 45 51
36. Miceli M. H., Dong L., Grazziutti M. L., Fassas A., Thertulien R., Van Rhee F., Barlogie B., Anaissie E. J., Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients Bone Marrow Transplantation 2006 37 9 857 864
37. Kontoyiannis D. P., Chamilos G., Lewis R. E., Giralt S., Cortes J., Raad I. I., Manning J. T., Han X., Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation Cancer 2007 110 6 1303 1306
38. Altes A., Remacha A. F., Sarda P., Sancho F. J., Sureda A., Martino R., Briones J., Brunet S., Canals C., Sierra J., Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis Bone Marrow Transplantation 2004 34 6 505 509
39. Altes A., Remacha A. F., Sarda P., Baiget M., Sureda A., Martino R., Briones J., Brunet S., Canals C., Sierra J., Early clinical impact of iron overload in stem cell transplantation. A prospective study Annals of Hematology 2007 86 6 443 447
40. Lee S. J., Klein J. P., Barrett A. J., Ringden O., Antin J. H., Cahn J.-Y., Carabasi M. H., Gale R. P., Giralt S., Hale G. A., Ilhan O., McCarthy P. L., Socie G., Verdonck L. F., Weisdorf D. J., Horowitz M. M., Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse Blood 2002 100 2 406 414
41. Bearman S. I., The syndrome of hepatic veno-occlusive disease after marrow transplantation Blood 1995 85 11 3005 3020
42. McDonald G. B., Hinds M. S., Fisher L. D., Schoch H. G., Wolford J. L., Banaji M., Hardin B. J., Shulman H. M., Clift R. A., Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients Annals of Internal Medicine 1993 118 4 255 267
43. Barker C. C., Anderson R. A., Sauve R. S., Butzner J. D., GI complications in pediatric patients post-BMT Bone Marrow Transplantation 2005 36 1 51 58
44. Hasegawa S., Horibe K., Kawabe T., Kato K., Kojima S., Matsuyama T., Hirabayashi N., Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors Bone Marrow Transplantation 1998 22 12 1191 1197
45. Kumar S., DeLeve L. D., Kamath P. S., Tefferi A., Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation Mayo Clinic Proceedings 2003 78 5 589 598
46. Alts A., Remacha A. F., Sureda A., Martino R., Briones J., Canals C., Brunet S., Sierra J., Gimferrer E., Iron overload might increase transplant-related mortality in haemotopoietic stem cell transplantation Bone Marrow Transplantation 2002 29 12 987 989
47. Maradei S. C., Maiolino A., de Azevedo A. M., Colares M., Bouzas L. F., Nucci M., Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation Blood 2009 114 6 1270 1275
48. Morado M., Ojeda E., Garcia-Bustos J., Aguado M. J., Arrieta R., Quevedo E., Navas A., Hernandez-Navarro F., Serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective cohort study Hematology 2000 4 6 505 512
49. Armand P., Kim H. T., Cutler C. S., Ho V. T., Koreth J., Ritz J., Alyea E. P., Antin J. H., Soiffer R. J., A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation Biology of Blood and Marrow Transplantation 2008 14 1 28 35
50. Sorror M. L., Maris M. B., Storb R., Baron F., Sandmaier B. M., Maloney D. G., Storer B., Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT Blood 2005 106 8 2912 2919
51. Majhail N. S., Lazarus H. M., Burns L. J., Iron overload in hematopoietic cell transplantation Bone Marrow Transplantation 2008 41 12 997 1003
52. McKay P. J., Murphy J. A., Cameron S., Burnett A. K., Campbell M., Tansey P., Franklin I. M., Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation Bone Marrow Transplantation 1996 17 1 63 66
53. Chotsampancharoen T., Gan K., Kasow K. A., Barfield R. C., Hale G. A., Leung W., Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation Pediatric Transplantation 2009 13 3 348 352
54. Efebera Y., Saliba R. M., Thandi R. S., Impact of pre-stem cell transplant ferritin levels on late transplant complications. A landmark analysis to determine potential role of iron chelation in improving transplant outcomes Biology of Blood and Marrow Transplantation 2009 15 supplement 2. abstract 254
55. Butt N. M., Clark R. E., Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia Bone Marrow Transplantation 2003 32 9 909 913
56. Lichtman S. M., Attivissimo L., Goldman I. S., Schuster M. W., Buchbinder A., Secondary hemochromatosis as a long-term complication of the treatment of hematologic malignancies American Journal of Hematology 1999 61 4 262 264
57. Lucarelli G., Angelucci E., Giardini C., Baronciani D., Galimberti M., Polchi P., Bartolucci M., Muretto P., Albertini F., Fate of iron stores in thalassaemia after bone-marrow transplantation The Lancet 1993 342 8884 1388 1391
58. Gattermann N., Porter J., Lopes L. F., Seymour J., Consensus statement on iron overload in myelodysplastic syndromes Hematology/Oncology Clinics of North America 2005 19 supplement 1 18 25
59. Rizzo J. D., Wingard J. R., Tichelli A., Lee S. J., Van Lint M. T., Burns L. J., Davies S. M., Ferrara J. L.M., Soci G., Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT) Bone Marrow Transplantation 2006 37 3 249 261
60. Bennett J. M., Consensus statement on iron overload in myelodysplastic syndromes American Journal of Hematology 2008 83 11 858 861
61. Wells R. A., Leber B., Buckstein R., Lipton J. H., Hasegawa W., Grewal K., Yee K., Olney H. J., Larratt L., Vickars L., Tinmouth A., Iron overload in myelodysplastic syndromes: a Canadian consensus guideline Leukemia Research 2008 32 9 1338 1353
62. McDonald G. B., Review article: management of hepatic disease following haematopoietic cell transplant Alimentary Pharmacology and Therapeutics 2006 24 3 441 452
63. Sucak G. T., Yegin Z. A., zkurt Z. N., Aki. Z., Karakan T., Akyol G., The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated? Bone Marrow Transplantation 2008 42 7 461 467
64. Kamble R. T., Selby G. B., Mims M., Kharfan-Dabaja M. A., Ozer H., George J. N., Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation 2006 12 5 506 510
65. Giardini C., Galimberti M., Lucarelli G., Polchi P., Angelucci E., Baronciani D., Gaziev D., Erer B., La Nasa G., Barbanti I., Muretto P., Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia British Journal of Haematology 1995 89 4 868 873
66. Angelucci E., Brittenham G. M., McLaren C. E., Ripalti M., Baronciani D., Giardini C., Galimberti M., Polchi P., Lucarelli G., Hepatic iron concentration and total body iron stores in thalassemia major The New England Journal of Medicine 2000 343 5 327 331
67. Wood J. C., Diagnosis and management of transfusion iron overload: the role of imaging American Journal of Hematology 2007 82 12 1132 1135
68. Di Tucci A. A., Matta G., Deplano S., Gabbas A., Depau C., Derudas D., Caocci G., Agus A., Angelucci E., Myocardial iron overload assessment by T2 magnetic resonance imaging in adult transfusion dependent patients with acquired anemias Haematologica 2008 93 9 1385 1388
69. Chacko J., Pennell D. J., Tanner M. A., Hamblin T. J., Wonke B., Levy T., Thomas P. W., Killick S. B., Myocardial iron loading by magnetic resonance imaging T2 in good prognostic myelodysplastic syndrome patients on long-term blood transfusions British Journal of Haematology 2007 138 5 587 593
70. Jensen P. D., Jensen F. T., Christensen T., Eiskjr H., Baandrup U., Nielsen J. L., Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool Blood 2003 101 11 4632 4639
71. Olivieri N. F., Brittenham G. M., Matsui D., Berkovitch M., Blendis L. M., Cameron R. G., McClelland R. A., Liu P. P., Templeton D. M., Koren G., Iron-chelation therapy with oral deferiprone in patients with thalassemia major The New England Journal of Medicine 1995 332 14 918 922
72. Olivieri N. F., The -thalassemias The New England Journal of Medicine 1999 341 2 99 109
73. Jensen P. D., Jensen F. T., Christensen T., Nielsen J. L., Ellegaard J., Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias Blood 2003 101 1 91 96
74. Brittenham G. M., Cohen A. R., McLaren C. E., Martin M. B., Griffith P. M., Nienhuis A. W., Young N. S., Allen C. J., Farrell D. E., Harris J. W., Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major American Journal of Hematology 1993 42 1 81 85
75. Taher A., El Rassi F., Isma'eel H., Koussa S., Inati A., Cappellini M. D., Correlation between serum ferritin levels and liver iron concentration, as determined by R2 MRI, in patients with thalassemia intermedia Thalassaemia International Federation Abstract Book 2008 105. Abstract MON04
76. Rose C., Ernst O., Hecquet B., Maboudou P., Renom P., Noel M. P., Yakoub-Agha I., Bauters F., Jouet J. P., Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long-term survivors after allogeneic hematopoietic stem cell transplantation Haematologica 2007 92 6 850 853
77. Kornreich L., Horev G., Yaniv I., Stein J., Grunebaum M., Zaizov R., Iron overload following bone marrow transplantation in children: MR findings Pediatric Radiology 1997 27 11 869 872
78. Majhail N. S., DeFor T., Lazarus H. M., Burns L. J., High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors Biology of Blood and Marrow Transplantation 2008 14 7 790 794
79. de la Serna J., Bornstein R., Garca-Bueno M.-J., Lahuerta-Palacios J.-J., Iron depletion by phlebotomy with recombinant erythropoietin prior to allogeneic transplantation to prevent liver toxicity Bone Marrow Transplantation 1999 23 1 95 97
80. Li C. K., Lai D. H., Shing M. M. K., Chik K. W., Lee V., Yuen P. M. P., Early iron reduction programme for thalassaemia patients after bone marrow transplantation Bone Marrow Transplantation 2000 25 6 653 656
81. Brugnara C., Chambers L. A., Malynn E., Goldberg M. A., Kruskall M. S., Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects Blood 1993 81 4 956 964
82. Angelucci E., Muretto P., Lucarelli G., Ripalti M., Baronciani D., Erer B., Galimberti M., Giardini C., Gaziev D., Polchi P., Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients Blood 1997 90 3 994 998
83. Boelaert J. R., de Locht M., Van Cutsem J., Kerrels V., Cantinieaux B., Verdonck A., Van Landuyt H. W., Schneider Y.-J., Mucormycosis during deferoxamine therapy is a siderophore-mediated infection: in vitro and in vivo animal studies Journal of Clinical Investigation 1993 91 5 1979 1986
84. Ibrahim A. S., Spellberg B., Edwards J. Jr., Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment Current Opinion in Infectious Diseases 2008 21 6 620 625
85. Gaziev D., Giardini C., Angelucci E., Polchi P., Galimberti M., Baronciani D., Erer B., Maiello A., Lucarelli G., Intravenous chelation therapy during transplantation for thalassemia Haematologica 1995 80 4 300 304
86. Ferriprox prescribing information,. 2007, http://www.ferriprox.com/
87. Ceci A., Baiardi P., Felisi M., Cappellini M. D., Carnelli V., De Sanctis V., Galanello R., Maggio A., Masera G., Piga A., Schettini F., Stefno I., Tricta F., The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients British Journal of Haematology 2002 118 1 330 336
88. Cohen A. R., Galanello R., Piga A., De Sanctis V., Tricta F., Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone Blood 2003 102 5 1583 1587
89. Cappellini M. D., Pattoneri P., Oral iron chelators Annual Review of Medicine 2009 60 25 38
90. Vichinsky E., Onyekwere O., Porter J., Swerdlow P., Eckman J., Lane P., Files B., Hassell K., Kelly P., Wilson F., Bernaudin F., Forni G. L., Okpala I., Ressayre-Djaffer C., Alberti D., Holland J., Marks P., Fung E., Fischer R., Mueller B. U., Coates T., A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease British Journal of Haematology 2007 136 3 501 508
91. Porter J., Galanello R., Saglio G., Neufeld E. J., Vichinsky E., Cappellini M. D., Olivieri N., Piga A., Cunningham M. J., Soulires D., Gattermann N., Tchernia G., Maertens J., Giardina P., Kwiatkowski J., Quarta G., Jeng M., Forni G. L., Stadler M., Cario H., Debusscher L., Porta M. D., Cazzola M., Greenberg P., Alimena G., Rabault B., Gathmann I., Ford J. M., Alberti D., Rose C., Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study European Journal of Haematology 2008 80 2 168 176
92. List A. F., Baer M. R., Steensma D., Iron chelation with deferasirox (Exjade ) improves iron burden in patients with myelodysplastic syndromes (MDS) Blood 2008 112 11. abstract 634
93. Vichinsky E., Clinical application of deferasirox: practical patient management American Journal of Hematology 2008 83 5 398 402